Abirapro – Prostate Cancer Treatment

oncology  /  Abirapro

Abirapro

Abirapro is a medication containing Abiraterone Acetate, used in the treatment of advanced prostate cancer. It works by inhibiting the enzyme CYP17, which plays a key role in the production of androge... Abirapro is a medication containing Abiraterone Acetate, used in the treatment of advanced prostate cancer. It works by inhibiting the enzyme CYP17, which plays a key role in the production of androgens (male hormones) that can stimulate the growth of prostate cancer cells. By reducing androgen levels in the body, Abirapro helps slow down the progression of the disease and can improve survival and quality of life in patients with metastatic castration-resistant prostate cancer (mCRPC). Abirapro is usually administered in combination with prednisone and should be taken under the supervision of an oncologist. Read more Hide

• Active ingredient:
  Abiraterone Acetate
• Manufacturer: Glenmark
• Dosage: 250 mg
• Dosage form: Tablets
• Units per pack: 120
• Delivery across Ukraine
• 100% original product